175 related articles for article (PubMed ID: 29207175)
1. Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.
Liu T; Qiu X; Zhao X; Yang R; Lian H; Qu F; Li X; Guo H
Oncol Rep; 2018 Feb; 39(2):659-666. PubMed ID: 29207175
[TBL] [Abstract][Full Text] [Related]
2. Frequent inactivation of SPARC by promoter hypermethylation in colon cancers.
Yang E; Kang HJ; Koh KH; Rhee H; Kim NK; Kim H
Int J Cancer; 2007 Aug; 121(3):567-75. PubMed ID: 17397030
[TBL] [Abstract][Full Text] [Related]
3. Aberrant promoter methylation of SPARC in ovarian cancer.
Socha MJ; Said N; Dai Y; Kwong J; Ramalingam P; Trieu V; Desai N; Mok SC; Motamed K
Neoplasia; 2009 Feb; 11(2):126-35. PubMed ID: 19177197
[TBL] [Abstract][Full Text] [Related]
4. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
5. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
[TBL] [Abstract][Full Text] [Related]
6. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of SPARC in human lung cancers.
Suzuki M; Hao C; Takahashi T; Shigematsu H; Shivapurkar N; Sathyanarayana UG; Iizasa T; Fujisawa T; Hiroshima K; Gazdar AF
Br J Cancer; 2005 Mar; 92(5):942-8. PubMed ID: 15756262
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin as a potential tumor suppressor inhibiting epithelial-to-mesenchymal transition but frequently silenced in prostate cancer by promoter methylation.
Tan W; Wang L; Ma Q; Qi M; Lu N; Zhang L; Han B
Prostate; 2015 Aug; 75(11):1197-205. PubMed ID: 25877612
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Analysis of Secreted Protein, Acidic and Rich in Cysteine in Prostate Carcinogenesis: Development of a 3D Nanostructured Bone-Like Model.
Ribeiro N; Costa-Pinheiro P; Henrique R; Gomez-Lazaro M; Pereira MP; Mansur AAP; Mansur HS; Jerónimo C; Sousa SR; Monteiro FJ
J Biomed Nanotechnol; 2016 Aug; 12(8):1667-78. PubMed ID: 29342345
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma.
Rodríguez-Jiménez FJ; Caldés T; Iniesta P; Vidart JA; Garcia-Asenjo JL; Benito M
Oncol Rep; 2007 Jun; 17(6):1301-7. PubMed ID: 17487382
[TBL] [Abstract][Full Text] [Related]
11. Potential Prognostic Role of
Fabrizio FP; Sparaneo A; Fontana A; Mazza T; Graziano P; Pantalone A; Parente P; Centra F; Orlando N; Trombetta D; Torre A; Ferretti GM; Taurchini M; Micco CMD; Maiello E; Fazio VM; Rossi A; Muscarella LA
Cells; 2020 Jun; 9(6):. PubMed ID: 32580473
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and prognosis potential of four gene promoter hypermethylation in prostate cancer.
Li Y; Meng L; Shi T; Ren J; Deng Q
Cell Biol Int; 2021 Jan; 45(1):117-126. PubMed ID: 32991011
[TBL] [Abstract][Full Text] [Related]
14. Random forest-based modelling to detect biomarkers for prostate cancer progression.
Toth R; Schiffmann H; Hube-Magg C; Büscheck F; Höflmayer D; Weidemann S; Lebok P; Fraune C; Minner S; Schlomm T; Sauter G; Plass C; Assenov Y; Simon R; Meiners J; Gerhäuser C
Clin Epigenetics; 2019 Oct; 11(1):148. PubMed ID: 31640781
[TBL] [Abstract][Full Text] [Related]
15. Improved response to nab-paclitaxel compared with cremophor-solubilized paclitaxel is independent of secreted protein acidic and rich in cysteine expression in non-small cell lung cancer.
Shao H; Tang H; Salavaggione OE; Yu C; Hylander B; Tan W; Repasky E; Adjei AA; Dy GK
J Thorac Oncol; 2011 Jun; 6(6):998-1005. PubMed ID: 21532503
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of secreted protein acidic and rich in cysteine gene and its significance in gastric cancer.
Shao S; Zhou NM; Dai DQ
World J Gastroenterol; 2019 Dec; 25(46):6713-6727. PubMed ID: 31857774
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
18. ssDNA-binding protein 2 is frequently hypermethylated and suppresses cell growth in human prostate cancer.
Liu JW; Nagpal JK; Sun W; Lee J; Kim MS; Ostrow KL; Zhou S; Jeronimo C; Henrique R; Van Criekinge W; Moon CS; Califano JA; Trink B; Sidransky D
Clin Cancer Res; 2008 Jun; 14(12):3754-60. PubMed ID: 18559593
[TBL] [Abstract][Full Text] [Related]
19. Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.
Gao J; Song J; Huang H; Li Z; Du Y; Cao J; Li M; Lv S; Lin H; Gong Y
J Exp Clin Cancer Res; 2010 Mar; 29(1):28. PubMed ID: 20338068
[TBL] [Abstract][Full Text] [Related]
20. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]